Puerto, Jershon L.
HRN: 22-60-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/12/2023
04/19/2023
IV
2.25g
Q8h
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes